What news is there though? The company has already given quite up-to-date guidance for FY20 results. So the only thing that will move the needle is forward guidance. The company has generally been on the conservative side, so there's a good chance it sells off on underwhelming forward guidance. The company has already said that the FY20 result was aided by "pantry stocking" and they are unsure when this will "unwind", so they will likely be cautious with any outlook as there is inevitably going to be a period of pantry destocking - babies aren't drinking more because of COVID
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-12530
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.78 |
Change
-0.040(0.83%) |
Mkt cap ! $3.504B |
Open | High | Low | Value | Volume |
$4.80 | $4.87 | $4.73 | $16.45M | 3.420M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9077 | $4.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.78 | 154935 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9077 | 4.770 |
2 | 23071 | 4.760 |
4 | 32973 | 4.750 |
5 | 54140 | 4.740 |
5 | 56948 | 4.730 |
Price($) | Vol. | No. |
---|---|---|
4.780 | 169401 | 4 |
4.790 | 121414 | 10 |
4.800 | 91176 | 9 |
4.810 | 39564 | 3 |
4.820 | 60932 | 5 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online